Trial intelligence / Profile preview

Subcutaneous vs vaginal progesterone for luteal support in frozen embryo transfer

2018-002897-27Phase 3Active

Sponsor
IBSA Group
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of progesterone in infertility and female infertility (2 arms), sponsored by IBSA Group. Primary endpoint: Clinical pregnancy rate. Started Jan 2019; status: active.

02

Drugs

progesterone
03

Conditions

infertilityfemale infertility

Beyond the preview

Go deeper on 2018-002897-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002897-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call